125 related articles for article (PubMed ID: 38780357)
1. Unusual presentation of ocular surface squamous neoplasia in a young healthy patient: A case report.
Knutsson KA; Tombolini B; Paganoni G; Rama P; Bandello F
Eur J Ophthalmol; 2024 May; ():11206721241256150. PubMed ID: 38780357
[TBL] [Abstract][Full Text] [Related]
2. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
Kaliki S; Bejjanki KM; Desai A; Mohamed A
Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
[TBL] [Abstract][Full Text] [Related]
3. Variable presentations of six conjunctival/limbal ocular surface squamous neoplasia (OSSN) cases: How good is our clinical judgment evidenced by the correlation to the histopathological findings and diagnosis?
Alharbi I; Alfawaz AM; Otaif W; Al-Dahmash SA; Alkatan HM
Int J Surg Case Rep; 2024 Mar; 116():109359. PubMed ID: 38330700
[TBL] [Abstract][Full Text] [Related]
4. Corneal melt in conjunctival intraepithelial neoplasia.
Warren N; Mercer RN; Haddad J; Magrath G; Rocha KM
Am J Ophthalmol Case Rep; 2020 Sep; 19():100689. PubMed ID: 32426552
[TBL] [Abstract][Full Text] [Related]
5. Topical interferon alpha-2b for treatment of noninvasive ocular surface squamous neoplasia with 360° limbal involvement.
Zarei-Ghanavati S; Alizadeh R; Deng SX
J Ophthalmic Vis Res; 2014; 9(4):423-6. PubMed ID: 25709765
[TBL] [Abstract][Full Text] [Related]
6. Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b.
Zarei-Ghanavati M; Mousavi E; Nabavi A; Latifi G; Mehrjardi HZ; Mohebbi M; Ghassemi H; Mirzaie F; Zare MA
Ocul Surf; 2018 Apr; 16(2):235-241. PubMed ID: 29306088
[TBL] [Abstract][Full Text] [Related]
7. Management of Ocular Surface Squamous Neoplasia with Topical and Intralesional Interferon Alpha 2B in Mexicans.
Nava-Castañeda Á; Hernández-Orgaz J; Garnica-Hayashi L; Ansart A; Matus G; Tovilla-Canales JL
Nepal J Ophthalmol; 2018 Jul; 10(20):143-150. PubMed ID: 31056557
[TBL] [Abstract][Full Text] [Related]
8. Treatment of conjunctival papilloma with topical interferon alpha-2b - case report.
Bolek B; Wylęgała A; Teper S; Kokot J; Wylęgała E
Medicine (Baltimore); 2020 Feb; 99(7):e19181. PubMed ID: 32049852
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell papilloma of the conjunctiva due to human papillomavirus (HPV): presentation of two cases and review of literature.
Kalogeropoulos C; Koumpoulis I; Papadiotis E; Zioga A; Gkrepi K; Pappa C; Paschides C; Malamou-Mitsi V; Aspiotis M
Clin Ophthalmol; 2012; 6():1553-61. PubMed ID: 23055678
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.
Pérez-García P; Burgos-Blasco B; Gómez-Calleja V; Vidal-Villegas B; Méndez-Fernández R; Gegúndez-Fernández JA; Díaz-Valle D
J Oncol Pharm Pract; 2023 Jun; 29(4):975-979. PubMed ID: 36131486
[TBL] [Abstract][Full Text] [Related]
11. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
Sturges A; Butt AL; Lai JE; Chodosh J
Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
[TBL] [Abstract][Full Text] [Related]
12. Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
Singh M; Gautam N; Kaur M
Int Ophthalmol; 2019 Feb; 39(2):295-301. PubMed ID: 29362973
[TBL] [Abstract][Full Text] [Related]
13. [Severe Conjunctival and Corneal Epithelial Dysplasia: A Case Series].
Jähnig A; Pfau K; Meyer P; Gatzioufas Z
Klin Monbl Augenheilkd; 2024 Apr; 241(4):402-405. PubMed ID: 38653294
[TBL] [Abstract][Full Text] [Related]
14. Amniotic Membrane Grafting for Ocular Surface Inflammation Following Topical Interferon Alpha 2b Therapy.
Shah SG; Mishra DK; Shah GY
J Interferon Cytokine Res; 2022 Mar; 42(3):137-139. PubMed ID: 35298286
[TBL] [Abstract][Full Text] [Related]
15. Ocular surface squamous neoplasia masquerading as superior limbic keratoconjunctivitis.
Moshirfar M; Khalifa YM; Kuo A; Davis D; Mamalis N
Middle East Afr J Ophthalmol; 2011 Jan; 18(1):74-6. PubMed ID: 21572741
[TBL] [Abstract][Full Text] [Related]
16. Limbal stem cell transplantation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2008; 8(7):1-58. PubMed ID: 23074512
[TBL] [Abstract][Full Text] [Related]
17. Ocular Surface Squamous Neoplasia With Coexistent Microbial Keratitis: Incidence, Risk Factors, Clinical Features, Microbiological Profile, and Treatment Outcome.
Kapoor AG; Vempuluru VS; Laghimshetty S; Roy A; Sharma S; Mishra DK; Mohamed A; Kaliki S
Cornea; 2022 Mar; 41(3):294-303. PubMed ID: 34294636
[TBL] [Abstract][Full Text] [Related]
18. Human Papilloma Virus Infection Does Not Predict Response to Interferon Therapy in Ocular Surface Squamous Neoplasia.
Galor A; Garg N; Nanji A; Joag M; Nuovo G; Palioura S; Wang G; Karp CL
Ophthalmology; 2015 Nov; 122(11):2210-5. PubMed ID: 26337001
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
Kim BH; Kim MK; Wee WR; Oh JY
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision.
Hanada K; Nishikawa N; Miyokawa N; Yoshida A
Int Ophthalmol; 2017 Feb; 37(1):71-78. PubMed ID: 27061904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
